Auris Medical Holding AG (EARS)
(Delayed Data from NSDQ)
$4.82 USD
-0.32 (-6.23%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.80 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.82 USD
-0.32 (-6.23%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.80 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
RedHill's (RDHL) RHB-204 Gets FDA Orphan Drug Designation
by Zacks Equity Research
RedHill (RDHL) gets Orphan Drug status from the FDA for the treatment of nontuberculous mycobacteria (NTM) disease.
New Strong Sell Stocks for August 23rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for August 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Savara Plunges on Failure of Late-Stage Study on Molgradex
by Zacks Equity Research
Savara's (SVRA) lead pipeline candidate, Molgradex, fails to meet primary endpoint in a phase III study evaluating it in a rare autoimmune lung disorder.
Auris (EARS) Expands Pipeline with Intranasal Betahistine
by Zacks Equity Research
Auris (EARS) announced that it has strengthened its pipeline by the addition of AM-125 as the third clinical-stage program, which allowed it to expand into the field of vestibular disorders.